Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
147.1 USD | +0.63% | +1.14% | +24.49% |
May. 27 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
May. 15 | UBS Raises Crane's Price Target to $152 From $120, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.49% | 8.41B | |
-26.63% | 10.92B | |
+0.08% | 6.96B | |
+50.79% | 2.13B | |
+9.97% | 1.66B | |
+10.13% | 920M | |
+16.64% | 892M | |
-7.94% | 655M | |
-7.88% | 625M | |
-20.22% | 393M |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication